Loading…
CIK 0001600004 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("first-light-asset-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 908 DEVICES INC | Common Stocks | $25.4M | 1.9%Prev: 2.1% | 4,836,186 SH | Increased+2,325,690 SH |
| ABIVAX SA-ADR | Common Stocks | $12.0M | 0.9%Prev: 0.8% | 88,674 SH | Increased-7,281 SH |
| AMYLYX PHARMACEUTICALS INC | Common Stocks | $40.5M | 3.1%Prev: 4.3% | 3,355,539 SH | Decreased-343 SH |
| ANAPTYS BIO INC | Common Stocks | $31.3M | 2.4%Prev: 2.9% | 646,238 SH | Increased-343,923 SH |
| APOGEE THERAPEUTICS INC | Common Stocks | $21.5M | 1.6% | 284,991 SH | New |
| ATRICURE INC | Common Stocks | $46.5M | 3.6%Prev: 3.0% | 1,175,445 SH | Increased+285,083 SH |
| AXOGEN INC | Common Stocks | $171.3M | 13.1%Prev: 9.8% | 5,233,326 SH | Increased-572,404 SH |
| BUTTERFLY NETWORK INC | Common Stocks | $10.7M | 0.8%Prev: 0.2% | 2,812,131 SH | Increased+1,684,133 SH |
| CENTESSA PHARMACEUTICALS LIMITED | Common Stocks | $57.0M | 4.4%Prev: 8.3% | 2,278,940 SH | Decreased-1,356,876 SH |
| CRINETICS PHARMACEUTICALS INC | Common Stocks | $55.6M | 4.3%Prev: 3.7% | 1,194,263 SH | Increased+252,747 SH |
| DISC MEDICINE INC | Common Stocks | $41.5M | 3.2%Prev: 1.4% | 523,167 SH | Increased+291,981 SH |
| DYNE THERAPEUTICS INC | Common Stocks | $3.0M | 0.2% | 155,231 SH | New |
| EDGEWISE THERAPEUTICS INC | Common Stocks | $39.1M | 3.0%Prev: 2.2% | 1,573,701 SH | Increased+158,707 SH |
| ESTABLISHMENT LABS HOLDINGS | Common Stocks | $27.2M | 2.1%Prev: 1.6% | 373,082 SH | Increased-45,276 SH |
| GUARDANT HEALTH | Common Stocks | $30.1M | 2.3%Prev: 1.6% | 294,751 SH | Increased+14,750 SH |
| HEALTH CATALYST INC | Common Stocks | $30.9M | 2.4%Prev: 3.6% | 12,910,941 SH | Decreased-525,279 SH |
| IRHYTHM TECHNOLOGIES | Common Stocks | $27.3M | 2.1%Prev: 2.5% | 153,871 SH | Increased-1,228 SH |
| ISHARES RUSSELL 2000 GROWTH ETF | Common Stocks | $245K | 0.0% | 760 SH | New |
| KORU MEDICAL SYSTEMS INC | Common Stocks | $24.5M | 1.9%Prev: 1.6% | 4,210,512 SH | Increased-317,225 SH |
| MADRIGAL PHARMACEUTICALS INC | Common Stocks | $38.9M | 3.0%Prev: 0.5% | 66,831 SH | Increased+55,292 SH |
| MIMEDX GROUP INC | Common Stocks | $20.6M | 1.6%Prev: 2.4% | 3,039,341 SH | Decreased-613,611 SH |
| NEOGENOMICS INC | Common Stocks | $118.0M | 9.0%Prev: 7.2% | 10,035,063 SH | Increased+107,794 SH |
| NEUROPACE INC | Common Stocks | $20.8M | 1.6%Prev: 1.3% | 1,349,482 SH | Increased-10,589 SH |
| ORGANOGENESIS HOLDINGS INC | Common Stocks | $20.0M | 1.5%Prev: 3.0% | 3,862,820 SH | Decreased-3,635,091 SH |
| PALVELLA THERAPEUTICS INC | Common Stocks | $74.2M | 5.7%Prev: 3.2% | 709,141 SH | Increased+167,597 SH |
| RHYTHM PHARMACEUTICALS INC | Common Stocks | $31.7M | 2.4%Prev: 1.7% | 295,844 SH | Increased+115,360 SH |
| SEPTERNA INC | Common Stocks | $17.3M | 1.3% | 620,811 SH | New |
| SI-BONE INC | Common Stocks | $99.2M | 7.6%Prev: 2.7% | 5,032,904 SH | Increased+3,115,001 SH |
| SIMULATIONS PLUS INC | Common Stocks | $35.9M | 2.7%Prev: 1.1% | 1,968,917 SH | Increased+1,201,157 SH |
| TANDEM DIABETES CARE INC | Common Stocks | $23.9M | 1.8% | 1,089,493 SH | New |
| TWIST BIOSCIENCE CORPORATION | Common Stocks | $36.2M | 2.8%Prev: 3.2% | 1,140,771 SH | Increased-54,112 SH |
| VERA THERAPEUTICS INC | Common Stocks | $44.0M | 3.4%Prev: 1.4% | 869,676 SH | Increased+362,579 SH |
| WAVE LIFE SCIENCES LTD | Common Stocks | $31.5M | 2.4% | 1,853,851 SH | New |
| 13F-HR |
| 0001999371-26-018014 |
| $1.65B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001999371-25-011375 | $771.3M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001999371-26-010896 | $1.12B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001999371-25-006243 | $875.7M | View |